Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.12 SGD
Change Today +0.001 / 0.82%
Volume 9.1M
QTVC On Other Exchanges
Symbol
Exchange
Singapore
OTC US
As of 10:22 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

qt vascular ltd (QTVC) Snapshot

Open
$0.12
Previous Close
$0.12
Day High
$0.13
Day Low
$0.12
52 Week High
07/30/14 - $0.51
52 Week Low
07/9/15 - $0.11
Market Cap
95.0M
Average Volume 10 Days
11.6M
EPS TTM
$-0.06
Shares Outstanding
772.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for QT VASCULAR LTD (QTVC)

Related News

No related news articles were found.

qt vascular ltd (QTVC) Related Businessweek News

No Related Businessweek News Found

qt vascular ltd (QTVC) Details

QT Vascular Ltd. designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases primarily in the United States, Europe, Asia, and internationally. The company offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries; GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature; and GliderfleX PTA balloon catheter for use in treating distal peripheral vessels. It also provides Glider percutaneous transluminal coronary angioplasty (PTCA) balloon catheter for the treatment of a range of complex lesions; Chocolate PTCA Balloon Catheter used in dilation of the coronary vascular system; Chocolate Touch, a drug coated balloon; and silk balloon catheter. The company was incorporated in 2013 and is based in Singapore.

Founded in 2013

qt vascular ltd (QTVC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

qt vascular ltd (QTVC) Key Developments

QT Vascular Ltd. Announces the Resignation of Tan Siew Hua as Joint Company Secretary, Effective from July 29, 2015

The Board of Directors of QT Vascular Ltd. announced the resignation of Ms. Tan Siew Hua as Joint Company Secretary of the company with effect from July 29, 2015. Following Ms. Tan Siew Hua's resignation, Ms. Low Mei Wan will be the sole company secretary of the company.

QT Vascular Ltd. Announces First Patients Enrolled in Clinical Study of Chocolate Touch PTCA Coronary Drugcoated Balloon

QT Vascular Ltd. announced it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic. This study initiation represents achievement of key milestone ahead of time. Working closely with local and US physicians, QT Vascular has embarked on a potentially revolutionary study to evaluate the clinical utility of the Chocolate Touch PTCA for the treatment of de novo coronary lesions. If successful, this study would provide initial evidence of a new and unique device that could be able to treat the most common coronary disease in a way that minimizes the placement of stents in at least in some lesion subsets. Stenting is currently the most commonly used treatment in coronary interventions, but it is a permanent implant that requires expensive long- term dual anti-platelet therapy and is associated with small but significant risks of fracture and late-thrombosis. The initial procedural outcomes with Chocolate Touch PTCA were successful in all 11 patients and importantly, no stent placement was required. There were also no cases with abrupt closure and no significant dissections were observed.

QT Vascular Ltd. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015

QT Vascular Ltd. reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of $3.298 million compared to $2.841 million a year ago. Loss from operating activities was of $6.616 million compared to $6.205 million a year ago. Loss before tax was $5.601 million compared to $9.173 million a year ago. Loss attributable to owners of the company was of $5.602 million or $0.01 per share compared to $9.174 million or $2.02 per share a year ago. Net cash used in operating activities was $8.852 million compared to $3.747 million a year ago. Purchase of property, plant and equipment was of $0.147 million compared to $0.093 million a year ago. Additions to intangible assets were of $1.029 million compared to $0.789 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QTVC:SP $0.12 SGD +0.001

QTVC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QTVC.
View Industry Companies
 

Industry Analysis

QTVC

Industry Average

Valuation QTVC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.0x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QT VASCULAR LTD, please visit www.qtvascular.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.